ESTUTC-5 New YorkLog in Sign up

CTY
City Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 11, 2026 1:05:10 PM EST

20.23USD+3.453%(+0.68)147,056

17.35Bid23.41Ask6.06Spread

CTY News

Day breaks

10:08 AM ESTCTY Initiates Coverage by Jefferies -- Price Target Announced at $32 ·

GuruFocus

08:33 AM ESTCTY Initiated Coverage by Oppenheimer -- Price Target Set at $46.00 ·

GuruFocus

07:36 AM ESTCTY Initiated Coverage by Goldman Sachs -- Early-Stage Biotech Rating ·

GuruFocus

07:00 AM ESTCity Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of CITY-RBP4 for the Treatment of Stargardt Disease ·

GlobeNewswire Inc.

06:11 AM ESTGoldman Sachs initiates City Therapeutics stock at Early-Stage Biotech ·

Investing.com

05:30 AM ESTCTY Initiates Coverage by Stifel -- Price Target Announced at $34.00 ·

GuruFocus

01:24 AM ESTStifel initiates City Therapeutics stock with buy on pipeline ·

Investing.com

01:06 AM ESTJefferies initiates City Therapeutics stock with buy rating ·

Investing.com

09:12 AM ESTCity Therapeutics to present drug trial data at ASH meeting ·

Investing.com

09:01 AM ESTPhase 1 Data for CITY-FXI, an RNAi Therapeutic Candidate for Thromboembolic Diseases, Selected for Oral Presentation at the 68th ASH Annual Meeting ·

GlobeNewswire Inc.

08:00 AM ESTCity Therapeutics to Present at Upcoming November Investor Conferences ·

GlobeNewswire Inc.

03:12 PM EDTRussell 2000 estimated to add 107 stocks in December rebalance - Stephens ·

Seeking Alpha

01:24 PM EDTRNAi drug developer City climbs after upsized IPO ·

Seeking Alpha

09:51 AM EDTRNAi drugmaker City prices upsized IPO at $18 per share ·

Seeking Alpha

08:40 AM EDTCity Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs ·

Quartz